TY  - CONF 
AU  - Fernández Montes, Ana
AU  - Martinez Lago, Nieves Purificacion
AU  - De La Cámara Gómez, Juan Cruz
AU  - Covela Rúa, Marta
AU  - Cousillas Castiñeiras, A
AU  - González Villarroel, Paula
AU  - Méndez Méndez, J
PY  - 2019
SN  - 0923-7534
UR  - http://hdl.handle.net/20.500.11940/15811
AB  - Introduction: Genomic studies of liquid biopsies in metastatic colorectal cancer (mCRC) have shown the evolutionary trajectory of wild type (WT) RAS colorectal tumours to mutant clones (mut). Recently, the disappearance of RAS mut has been reported...
LA  - eng
TI  - FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial
DO  - 10.1093/annonc/mdz155.088
KW  - CHUF
KW  - CHUAC
KW  - CHUO
KW  - CHUVI
KW  - HULA
VL  - 30
ER  -